SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

20/20 Biolabs, Inc. (AIDX) News

Track canonical SquawkNews coverage tagged to AIDX, 20/20 Biolabs, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 15 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol AIDX Asset equity Sector Markets 90 days 15 Last 0.4187 Updated Sep 29, 2026, 12:38 PM UTC Open live news feed
L 20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model President and CEO Jonathan Cohen to Discuss Implications for Multi-Cancer Early Detection, Preliminary Interest from Laboratories Across the United States, and New State Funding for Firefighter Cancer ScreeningWebinar to REGULATION | Sep 29, 2026, 12:38 PM UTC L HEALWELL AI to Present at the Cantech Investment Conference on October 8th in Toronto Toronto, Ontario--(. - September 28, 2026) - HEALWELL AI Inc. TSX:AIDX (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its p NEWS | Sep 28, 2026, 08:03 PM UTC L HEALWELL AI Inc. (AIDX) Expands SMART Summary to 400+ New Brunswick Clinicians HEALWELL AI Inc. deployed its DARWEN-powered SMART Summary to 400+ clinicians in New Brunswick, expanding integration with Intrahealth EMRs and laying groundwork for broader commercialization across Canada and internatio NEWS | Sep 23, 2026, 10:01 AM UTC L HEALWELL Expands SMART Summary AI Deployment Across New Brunswick Toronto, Ontario--(. - September 23, 2026) - HEALWELL AI Inc. TSX:AIDX (OTCQX: HWAIF) ("HEALWELL AI" or the "Company"), a healthcare artificial intelligence company focused on preventative care, today announced the deplo NEWS | Sep 23, 2026, 10:01 AM UTC M 20/20 Biolabs gets Nasdaq notice over $2.5m stockholders’ equity rule On Sept. 3, 2026, 20/20 Biolabs received a Nasdaq notice that it failed the $2.5 million stockholders’ equity requirement. The company has 45 days to submit a compliance plan and may receive up to 180 days to regain comp REGULATION | Sep 10, 2026, 08:15 PM UTC L HEALWELL to use DARWEN™ to match WELLTRUST™ clinical trials HEALWELL AI Inc. said its DARWEN™ will power AI-driven clinical trial matching for WELLTRUST™, a network of more than 100,000 consented patients. EQUITY | Sep 08, 2026, 10:36 AM UTC L 20/20 Biolabs outlines FDA engagement and Medicare pathway 20/20 Biolabs said it presented FDA engagement progress, a Medicare reimbursement opportunity and Q2 commercial growth in an original SEC 8-K filing. REGULATION | Sep 02, 2026, 08:44 PM UTC L Stifel maintains Healwell AI buy rating and C$2.25 target Baystreet reports Stifel maintains a Buy rating on Healwell AI Inc. and keeps its C$2.25/share price target. EQUITY | Sep 02, 2026, 03:21 PM UTC M HealWELL AI wins multi-year Iowa Health Information Exchange software contract HealWELL AI said it secured a multi-year contract to deploy its proprietary AI search and summarization software across Iowa’s Health Information Exchange. The agreement is with Converge He… EQUITY | Sep 01, 2026, 10:40 AM UTC L HEALWELL agreement to deploy AI SMART Search and SMART Summary HEALWELL AI Inc. said it has entered into an agreement with Converge Health Iowa to deploy AI-powered SMART Search and SMART Summary across Iowa’s health information exchange. EQUITY | Sep 01, 2026, 10:06 AM UTC L AIDX reschedules investor webinar to 2:00 p.m. ET Sept. 2, 2026 AIDX rescheduled its investor webinar to 2:00 p.m. Eastern Time on September 2, 2026 to discuss OneTest™ revenue and expanding commercial opportunity. EQUITY | Aug 28, 2026, 10:26 PM UTC L AIDX to host investor webinar Sept. 2, 2026 on OneTest revenue AIDX said it will host an investor webinar on September 2, 2026 to discuss OneTest™ revenue and expanding commercial opportunity. EQUITY | Aug 26, 2026, 12:31 PM UTC L 20/20 BioLabs reports Q2 2026 results; cancer test revenue hits record 20/20 BioLabs (AIDX) reports its second quarter 2026 financial results and notes recent operational progress, stating cancer test revenue reaches a record quarterly level. EARNINGS | Aug 17, 2026, 12:31 PM UTC L AIDX: Hosts Investor Webinar AIDX hosts investor webinar on August 5 EQUITY | Jul 30, 2026, 12:31 PM UTC H Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket Shares of Super Micro Computer Inc (NASDAQ: SMCI ) rose sharply in pre-market trading after the company provided strong preliminary results for the fourth quarter. Super Micro announced its backlog grew to "record levels MACRO | Jul 22, 2026, 08:47 AM UTC